Cutler Group’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $41K | Sell |
9,000
-300
| -3% | -$1.37K | 0.01% | 425 |
|
|
2023
Q4 | $38K | Hold |
9,300
| – | – | ﹤0.01% | 718 |
|
|
2023
Q3 | $27K | Hold |
9,300
| – | – | ﹤0.01% | 818 |
|
|
2023
Q2 | $22K | Hold |
9,300
| – | – | ﹤0.01% | 806 |
|
|
2023
Q1 | $21K | Sell |
9,300
-15,100
| -62% | -$34.1K | ﹤0.01% | 842 |
|
|
2022
Q4 | $85K | Buy |
24,400
+13,918
| +133% | +$48.5K | 0.01% | 670 |
|
|
2022
Q3 | $388K | Buy |
10,482
+7,815
| +293% | +$289K | 0.03% | 324 |
|
|
2022
Q2 | $50K | Sell |
2,667
-7,079
| -73% | -$133K | ﹤0.01% | 885 |
|
|
2022
Q1 | $263K | Buy |
9,746
+9,546
| +4,773% | +$258K | 0.01% | 514 |
|
|
2021
Q4 | $4K | Sell |
200
-1,400
| -88% | -$28K | ﹤0.01% | 1860 |
|
|
2021
Q3 | $41K | Buy |
1,600
+400
| +33% | +$10.3K | ﹤0.01% | 1272 |
|
|
2021
Q2 | $38K | Buy |
1,200
+500
| +71% | +$15.8K | ﹤0.01% | 1333 |
|
|
2021
Q1 | $24K | Buy |
700
+540
| +338% | +$18.5K | ﹤0.01% | 1419 |
|
|
2020
Q4 | $5K | Sell |
160
-40
| -20% | -$1.25K | ﹤0.01% | 1566 |
|
|
2020
Q3 | $7K | Buy |
+200
| New | +$7K | ﹤0.01% | 1384 |
|
|
2020
Q2 | – | Sell |
-900
| Closed | -$30K | – | 1997 |
|
|
2020
Q1 | $30K | Buy |
+900
| New | +$30K | ﹤0.01% | 907 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2015 |
|